Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

Welcome, Introductions, and Pre-session Survey

The Rationale for More Aggressive Therapy: From Extensive to Limited Disease Settings

Tumor Board 1: Integrating Multiple Therapeutic Modalities in Curative Settings for Limited-Stage SCLC

Tumor Board 2: Updates in First Line Therapy for Extensive-Stage SCLC

Tumor Board 3: Current and Emerging Therapies for Relapsed or Refractory Extensive-Stage SCLC